NCT07537764

Brief Summary

This study examines how adolescents with trauma-related symptoms respond to stress and strong emotions. The study assesses brain activity, physiological responses, and behavior during experimental tasks that involve responding to potential threats, regulating emotions, and repeatedly imagining details of a personally experienced stressful or traumatic event using a script-driven imagery task. The study evaluates whether repeated imaginal exposure is associated with changes in anxiety and physiological responses across sessions, and whether baseline patterns of threat reactivity and emotion regulation are associated with individual differences in response to the exposure task. Outcomes include self-reported anxiety, subjective distress ratings, and psychophysiological indices such as heart rate, skin conductance, and electromyographic activity. The goal of this research is to improve understanding of biobehavioral processes related to trauma exposure in adolescents and to identify potential predictors of response to exposure-based intervention components relevant to posttraumatic stress disorder (PTSD).

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for early_phase_1

Timeline
59mo left

Started Apr 2026

Longer than P75 for early_phase_1

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Apr 2026Mar 2031

First Submitted

Initial submission to the registry

March 30, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
16 days until next milestone

First Posted

Study publicly available on registry

April 17, 2026

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2031

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2031

Last Updated

April 17, 2026

Status Verified

April 1, 2026

Enrollment Period

4.9 years

First QC Date

March 30, 2026

Last Update Submit

April 13, 2026

Conditions

Keywords

Adolescent PTSDTrauma Exposure

Outcome Measures

Primary Outcomes (5)

  • State Anxiety (State and Trait Anxiety Inventory for Children - State Scale)

    Baseline (Visit 1, prior to first script-driven imagery task) and 1 week after baseline (Visit 2, following repeated imaginal exposure)

  • Corrugator Supercilii Electromyography (EMG) Reactivity

    During script-driven imagery tasks at baseline (Visit 1) and 1 week after baseline (Visit 2)

  • Heart Rate Reactivity During Script-Driven Imagery

    During script-driven imagery tasks at baseline (Visit 1) and 1 week after baseline (Visit 2)

  • Skin Conductance Reactivity During Script-Driven Imagery

    During script-driven imagery tasks at baseline (Visit 1) and 1 week after baseline (Visit 2)

  • Posttraumatic Stress Disorder Symptoms (UCLA PTSD Reaction Index for DSM-5)

    Baseline (Visit 1) and 1 month after baseline (Visit 3)

Secondary Outcomes (1)

  • Subjective units of distress (SUDS)

    Visit 1 (baseline) to Visit 2 (1 week)

Study Arms (1)

Exposure Arm

EXPERIMENTAL
Behavioral: Repeated imaginal exposure: Script Driven Imagery (SDI) task

Interventions

Repeated administration (5 repetitions) of a script including details of the individual's exposure to a traumatic event.

Exposure Arm

Eligibility Criteria

Age14 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Adolescent of any sex, race, or ethnicity; between the ages of 14 and 18 years old.
  • Accompaniment by a caregiver willing to participate. Note: Adolescents aged 18 years old are able to provide their own consent though still require caregiver participation to be eligible for study participation.
  • Ability to comprehend English. Rationale: Public census data indicates that the overwhelming majority of youth in the local community are English-speaking (\>98%), inclusive of multi-lingual households.
  • Endorsement of exposure to one or more potentially traumatic event(s), as defined by DSM-5 Criterion A event, that the adolescent remembers and is able to verbalize.
  • A total score ≥15 on the Child and Adolescent Trauma Screen (CATS) or report at least one clinically significant symptom on Intrusion/Re-experiencing, Avoidance, and Hyperarousal symptom domains, as defined by DSM-5 PTSD criteria, and one area of impairment.

You may not qualify if:

  • Previous diagnosis indicating intellectual disability or pervasive developmental disorder that would preclude participant from understanding study procedures.
  • Active psychosis, bipolar disorder, or a comorbid condition that requires a higher level of immediate care (e.g., anorexia nervosa, alcohol withdrawal).
  • Active suicide risk with ideation, plan and intent and/or recent (past 6 months) hospitalization for suicidality. These individuals will be referred directly for immediate services and treatment. All participants who endorse suicidal ideation will be engaged in safety planning as part of the study protocol.
  • Individuals on psychotropic medications must be stabilized on the medication for at least four weeks prior to study start date.
  • Individuals currently engaged in trauma-focused, exposure-based treatment.
  • Caregiver, parent, or legal guardian of an adolescent between the ages of 14 and 18 years old.
  • Ability to comprehend English.
  • \. Previous diagnosis indicating intellectual disability or pervasive developmental disorder that would preclude participant from understanding study procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

potassium channel subfamily K member 3

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Central Study Contacts

Rachel Siciliano, Ph.D.

CONTACT

Carla Kmett Danielson, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 30, 2026

First Posted

April 17, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

March 1, 2031

Study Completion (Estimated)

March 1, 2031

Last Updated

April 17, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

A de-identified data set will use unique identifier numbers that are not related to any personal identifying information. After the completion of the K23 major aims papers, data from the K23 study will be made available to other researchers upon request. A written request should state the investigators names, affiliated institution, and proposed specific research question. Investigators should also submit a conflict of interest statement. To gain access to the data, the investigator making the request must provide: (1) agreement to use data only for research purposes; (2) a commitment not to identify any individual participant (information will be de-identified); (3) a promise to secure the data according to NIMH, institutional, and IRB guidelines to ensure data safety and participant confidentiality; and (4) a commitment to destroy or return the data after the specified analyses are completed. All data sharing will follow the guidelines and rules of the NIH and IRB.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Data from the K23 study will be made available to other researchers upon request after the completion of the K23 major aims papers, and available for 5 years after that date.
Access Criteria
Data from the K23 study will be made available to other researchers upon written request stating the investigators names, affiliated institution, and proposed specific research question. Investigators should submit a conflict of interest statement. To gain access to the data, the investigator making the request must provide: (1) agreement to use data only for research purposes; (2) a commitment not to identify any individual participant (information will be de-identified); (3) a promise to secure the data according to NIMH, institutional, and IRB guidelines to ensure data safety and participant confidentiality; and (4) a commitment to destroy or return the data after the specified analyses are completed.

Locations